Title:
結腸癌を有する患者の生存期間のKIAA1456発現による予測
Document Type and Number:
Japanese Patent JP2014513975
Kind Code:
A
Abstract:
The invention relates to methods for deciding on the therapy in a subject suffering from colorectal cancer as well as for predicting the clinical outcome of a patient which suffers from colorectal cancer based on the expression level of KIAA1456 comprising determining the expression level of the KIAA1456 gene. The invention relates as well to kits and uses thereof comprising reagents adequate for the determination of the expression level of the KIAA1456 gene.
Inventors:
Juan, Carlos, Lacal, San Juan
Fatima, Valdes, Mora
Fatima, Valdes, Mora
Application Number:
JP2014509758A
Publication Date:
June 19, 2014
Filing Date:
May 11, 2012
Export Citation:
Assignee:
TRASLATIONAL CANCER DRUGS PHARMA, S.L.
International Classes:
C12Q1/68; G01N33/50; G01N33/53; G01N33/574; G01N33/68; C12N15/09
Foreign References:
| US20090215046A1 | 2009-08-27 | |||
| WO2006015312A2 | 2006-02-09 |
Other References:
JPN6016009797; '"Ｈｏｍｏ ｓａｐｉｅｎｓ ｍＲＮＡ ｆｏｒ ＫＩＡＡ１４５６ ｐｒｏｔｅｉｎ， ｐａｒｔｉａｌ ｃｄｓ． ＡＢ０４０８８９．１"' ＡＢ０４０８８９．１， ［ｏｎｌｉｎｅ］， Ｎａｔｉｏｎａｌ Ｃｅｎｔｅｒ ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｉｎｆｏｒｍａｔｉｏｎ， ２００１年２月２２日掲載， ２０１６年３月８日
JPN6016009799; 'Ｃａｎｃｅｒ Ｓｃｉｅｎｃｅ' ２００９， Ｖｏｌ．１００， Ｎｏ．２， ｐｐ．１９５-１９９
JPN6016009794; 'ＤＮＡ Ｒｅｓｅａｒｃｈ' ２０００， Ｖｏｌ．７， ｐｐ．１４３-１５０
JPN6016009799; 'Ｃａｎｃｅｒ Ｓｃｉｅｎｃｅ' ２００９， Ｖｏｌ．１００， Ｎｏ．２， ｐｐ．１９５-１９９
JPN6016009794; 'ＤＮＡ Ｒｅｓｅａｒｃｈ' ２０００， Ｖｏｌ．７， ｐｐ．１４３-１５０
Attorney, Agent or Firm:
Hirohito Katsunuma
Yukitaka Nakamura
Noritaka Yokota
Yukitaka Nakamura
Noritaka Yokota